Baltimore Innovation Week 2017

Le`Rhone is part of the technology leadership at The Archer Group and oversees the front end development and animation disciplines. He also oversees emerging technology research via the Archer Innovations program. This team is currently exploring Virtual Reality, Machine Learning, and Artificial Intelligence, and uses this research to educate internal teams and find new opportunities to create meaningful experiences for Archer's clients.

Le’Rhone’s decade of experience in both design and business helps Archer’s work achieve the right balance between meeting the client’s business goals and creating a digital experience worth talking about. He has applied this knowledge to projects for clients such as Wawa Foods, Morgan Stanley, J.P. Morgan Chase, DuPont, March of Dimes, and BarclayCard US.

Hadley VanRenterghem, originally from Ann Arbor, Michigan, is a sophomore at Johns Hopkins University majoring in Biomedical Engineering.

Dr. Miriam Boer is the founder of Sonify Biosciences, an ultrasound-based hyperthermia device company based in the Alexandria LaunchLabs incubator in New York City. Dr. Boer founded Sonify Biosciences in 2012 after receiving her PhD in biochemistry from the University of Maryland College Park, where she studied mechanosensation in bacterial cell membranes. Prior to that, Dr. Boer studied chemistry at New York University and worked as a color and flavor chemist in international research and development at PepsiCo.

Tom Kraak is a JavaScript developer at Oath, a subsidiary of Verizon, which houses 50+ media and technology brands including AOL, Yahoo, and HuffPost. He is passionate about learning, teaching, and the web platform. Tom combines these passions in frequent contributions to his favorite open source projects on GitHub. Besides the long-standing Academy course at Betamore, he teaches and mentors at Thinkful, Baltimore NodeSchool and various local meetups for junior web developers.

John H. Cammack is Managing Partner of Cammack Associates, which specializes in early stage investing in enterprises advancing brain fitness, business services and educational attainment. Representative investments include Curiosityville, Moodlerooms, Allovue, Calvert Education Services, UnboundConcepts, ReifyHealth, Interaxom, eMindful, Pear Therapeutics, Fusiform and Happlify.

From 1991 to 2009, Mr. Cammack was a senior executive at T. Rowe Price where he served as Division Head and member of the firm’s Operating Steering Committee, Institutional Marketing Steering Committee, Compliance Oversight Committee and member of T. Rowe Price Investment Services Board. Current board assignments included CureViolence.org, PersonalGenome.org, ABAG (Association of Baltimore Area Grantmakers), Baltimore Corps, Betamore, Fusiform, and Calvert Education Services. Past roles include the Chairmanship of the United Way of Central Maryland and the Mutual Fund Education Alliance.

Mr. Cammack graduated from Denison University with a BA in History and received his MBA from Columbia University.

Natalie D. Eddington, PhD, FAAPS, FCP, is dean of the University of Maryland School of Pharmacy (UMSOP) and a professor of pharmaceutical sciences. She is also executive director of University Regional Partnerships for the University of Maryland, Baltimore (UMB).

Dr. Eddington is a nationally known expert in drug delivery and pharmacokinetics. Her research focuses on various medications used in the treatment of cancer, epilepsy, arthritis, and drugs of abuse and on understanding the role of biopharmaceutics and pharmacokinetics in elucidating the underlying mechanisms important in optimizing drug therapy. 

Under Dr. Eddington’s leadership, the School of Pharmacy has established a number of centers and programs including the FDA-supported Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI), which is a collaborative agreement with the FDA to promote innovation in support of the development and evaluation of safe and effective products. Dr. Eddington has designed numerous international regulatory courses for clinicians and scientists from South Korea, Argentina, Brazil, the United States, and Japan on the United States’ drug development process and the FDA regulatory infrastructure surrounding medication and device development. Most recently, under Dr. Eddington’s leadership, the School has launched a transformational pharmapreneurism initiative, which seeks to position the School’s world class faculty, its wonderful students, and exceptional staff to achieve their career aspirations and address our nation’s health care, research, policy, and societal needs.

In November 2015, Stacia became the creator and producer of Baltimore: The Rise of Charm City, a radio and podcast series that tells intergenerational stories of place and memory in Baltimore City. Baltimore: The Rise of Charm City is part of the Association of Independents in Radio (AIR)’s 2015 Finding America: Localore project and is produced in partnership with WEAA 88.9.

Dr. Greg Walsh is an assistant professor at the University of Baltimore where he is the graduate program director for the MS in Interaction Design and Information Architecture as well as the UX Design program. He is an interaction design researcher who focuses on user-centered design. In his almost 20 years of Baltimore City residency, Dr. Walsh has worked at a number of Baltimore-based interaction design firms and continues to focus on innovation through mentoring start-ups in the art of user-centered design. He is ruggedly handsome and a recipient of a Google Faculty Research Award.